Reflectiz
Reflectiz is a web exposure management platform that enables organizations to proactively identify, monitor, and mitigate security, privacy, and compliance risks across their digital environments. It provides comprehensive visibility and control over first, third, and even fourth-party components like scripts, trackers, and open-source libraries—elements that are often missed by traditional security tools.
The unique advantage of Reflectiz is that it operates remotely, without embedding code on customer websites. This ensures no impact on site performance, no access to sensitive user data, and no additional attack surface. By continuously monitoring all publicly available components, Reflectiz identifies hidden risks in your digital supply chain, helping to detect vulnerabilities and compliance issues in real-time.
With a centralized dashboard, Reflectiz gives businesses a holistic view of their web assets, making it easier to manage risk across all digital properties. The platform allows teams to establish baselines for approved behaviors, swiftly identifying deviations that may indicate threats.
Reflectiz is particularly valuable for industries such as eCommerce, healthcare, and finance, where managing third-party risks is crucial. It helps businesses enhance security, reduce attack surfaces, and maintain compliance without requiring any changes to website code, offering continuous monitoring and detailed insights into external component behaviors.
Learn more
Jama Connect
Jama Connect®, a product development platform, uniquely creates Living Requirements™. This digital thread is created through siloed, test, and risk activities to provide end to end compliance, risk mitigation, process improvement, and compliance. Companies creating complex products, systems, and software can now define, align, and execute on what they need. This reduces the time and effort required to prove compliance and saves on rework. You can be sure of success by choosing a solution that is easy-to-use, flexible, and offers support and services that are adoption-oriented.
Learn more
Medrio
Medrio's Electronic Data Capture (EDC) platform and complimenting eClinical solutions such as ePRO, RTSM, eConsent, and Direct Data Capture (DDC) have been trusted by major pharmaceutical, biotech, CRO, animal health, medical device, and diagnostic companies since 2005.
We are known for our easy-to-use solutions, delivering speed and simplicity to clinical trials of all phases, sizes, and complexities. Medrio users can build their databases in an average of 2.8 weeks with no programming required, make mid-study changes with just a few clicks of a mouse, and much more.
From bolt-on capabilities to full-service offerings, Medrio offers flexible, modular solutions that give our customers exactly what they need – and none of what they don’t. Our innovative software, as well as the robust and flexible training and support resources we provide our customers, have earned us a 98% customer satisfaction rating.
Learn more
Koneksa
Koneksa stands out as a prominent digital biomarker firm catering to the pharmaceutical and biotechnology sectors, focusing on the creation, testing, and validation of digital biomarkers that assist clients in assessing how treatments affect patients. Established in 2013, Koneksa delivers comprehensive remote clinical trial support by integrating digital health technologies, therapeutic knowledge, and swift, user-friendly remote data gathering to enhance understanding of patient health outcomes. Their innovative and validated data algorithms are designed for immediate use in treatment development initiatives, facilitating the detection of signals more rapidly than conventional methods. The company's cloud-based Software as a Service (SaaS) platform enables real-time integration of multiple endpoints, providing instant access to data and supporting informed, cost-effective decision-making early in the trial process. Additionally, this platform’s capability to gather extensive remote data at higher frequencies presents opportunities for obtaining ecologically valid measures, which can lead to a reduction in sample size while maintaining the integrity of the research. By continuously evolving their tools and methodologies, Koneksa aims to redefine how clinical trials are conducted in the modern age.
Learn more